[Liver tolerance of niflumic acid during treatment of degenerative rheumatic disease].
D000814:Aniline Compounds / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005461:Fluorine / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000187:drug effects*; D009539:Nicotinic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids; D005461:Fluorine
Zur Leberverträglichkeit von Nifluminsäure währedn der Behandlung degenerativ-rheumatischer Erkrankungen.